According to a new report, published by KBV research, The Global Artificial Intelligence in Diagnostics Market size is expected to reach $5.80 billion by 2031, rising at a market growth of 21.3% CAGR during the forecast period.
The Software segment is leading Global Artificial Intelligence in Diagnostics Market by Component in 2023; thereby, achieving a market value of $2.34 billion by 2031. This growth can be attributed to the widespread adoption of AI-driven diagnostic platforms across healthcare institutions and continuous advancements in machine learning and deep learning algorithms. AI-powered software solutions are increasingly integrated into medical imaging, pathology, and cardiology, enabling faster and more accurate diagnoses. The increasing digitization of healthcare records and the growing reliance on AI for predictive analytics have further fuelled the demand for software solutions in diagnostics.
The Chest & Lung segment would showcase a CAGR of 20.5% during (2024 - 2031). This is largely due to the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer. AI-driven imaging analysis has revolutionized chest X-ray and CT scan interpretation, enabling faster and more accurate detection of lung abnormalities. AI applications have been particularly beneficial in identifying early-stage lung cancer and assessing COVID-19-related complications, further accelerating adoption in this segment.
Full Report: https://www.kbvresearch.com/artificial-intelligence-in-diagnostics-market/
The North America region dominated the Global Artificial Intelligence in Diagnostics Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.64 billion by 2031. The Europe region is experiencing a CAGR of 20.8% during (2024 - 2031). Additionally, The Asia Pacific region would exhibit a CAGR of 22.4% during (2024 - 2031).
By Component
By Diagnosis
Unique Offerings 
